Advanced search
Publication Cover
Autoimmunity Volume 35, 2002 - Issue 7
Submit an article Journal homepage
63
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment

Eduardo Cabrera-Rode National Institute of Endocrinology, Havana, Cuba
,
Pedro Perich National Institute of Endocrinology, Havana, Cuba
,
Oscar Diaz-Horta National Institute of Endocrinology, Havana, Cuba
,
Claudio Tiberti University of Rome "La Sapienza", Rome, Italy
,
Gisela Molina National Institute of Endocrinology, Havana, Cuba
,
Celeste Arranz National Institute of Endocrinology, Havana, Cuba
,
Juana M. Martin National Institute of Endocrinology, Havana, Cuba
,
Manuel Licea National Institute of Endocrinology, Havana, Cuba
,
Alberto De Leiva Hospital de Sant Pau, University of Barcelona, Barcelona, Spain
,
Manuel Puig-Domingo Hospital de Sant Pau, University of Barcelona, Barcelona, Spain
&
Umberto Dimario University of Rome "La Sapienza", Rome, Italy
 show all
Pages 469-474 | Published online: 07 Jul 2009

  • Del Prete. G.F., Betterle, C. and Radovan, D. (1977) "Incidence and significance of islet cell antibodies in different types of diabetes mellitus", Diabetes 26, 909-915.
  • Di Mario, U., Irvine, W.J., Borsey, D.Q., Kyner, J.L., Weston, J. and Galfo, C. (1983) "Immune abnormalities in diabetic patients not requiring insulin at diagnosis". Diubetologuia 25, 392-395.
  • Groop, L.C., Groop, P.H. and Koskimies, S. (1986) "Relationship between ß-cell function and HLA antigens in patients with type 2 (non-insulin dependent) diabetes". Diabetologia 29, 757-760.
  • Groop, L.C., Miettinen, A., Groop, P.H., Meri, S., Koskimies, S. and Bottazzo, G.F. (1988) "Organ-specific autoimmunity and HLADR antigens as markers for ß-cell destruction in patients with type II diabetes", Diubeies 37, 99-103.
  • Lipton, R. and LaPorte, R. (1989) "Epidemiology of islet cell antibodies". Epidemiologie Rev. 11, 182-203.
  • Gottsater, A., Landin-Olson, M., Femlund, P. Lemmark, A. and Sundkvist, G. (1993) "ß-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type Il diabetic patients", Diabetes Care 16, 902-910.
  • Groop, L., Bottazo, G.F. and Doniach, D. (1986) "Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis", Diabetes 35, 237-241.
  • Cabrera-Rode, E., Licea, M., Molina, G., Díaz-Horta, O., Arranz, C. and Uriarte, A. (1995) "Immunogenetic. clinical and metabolic characterization of non-insulin dependent diabetes mellitus (NIDDM) according to the presence of islet cell antibodies". Avances en Diubetologia 10, 101-110.
  • Kobayashi, T., Itoh, T., Kosaka, K., Sato, K. and Tsuji, K. (1987) "Time course of islet cell antibodies and ß-cell function in noninsulin-dependent stage of type 1 diabetes", Diabetes 36, 510-517.
  • Kobayashi, T., Tamemoto, K., Nakanishi, K., Kalo, N., Okubo, M., Kajio, H., et al. (1993) "Immunogenetic and clinical characteriztion of slowly progressive IDDM", Diabetes Care 16, 780-788.
  • Cabrera-Rode, E., Díaz.-Horta, O., Rendón, A., Molina, G., Vera, M., Licea, M., et al. (1997) "Prevalence of Islet Cell Antibodies (ICA) in diabetes mellitus and other diseases in Cubans", Autoimmunity 26, 7-10.
  • Keller, R.J., Eisenbarth, G.S. and Jackson, R.A. (1993) "Insulin prophylaxis in individuals at high risk of type 1 diabetes". Lancet 341, 927-928.
  • Appel, M.C., Dotta, F., O'Neil, J. and Eisenbarth, G.S. (1989) "Beta cell activity regulates the expression of islet antigenic determinants". Diabetologia 32, 461A.
  • Malone, J.I. (1991) In: Rifkin, H., Colwell, J.A. and Taylor, S.I., eds. The Role of Exogenous Insulin in the Pathogenesis of Autoimmune Diabetes Mellitus (Elsevier Science Publisher B.V. Diabetes 1991). pp. 1022-1025.
  • Shah, S.C., Malone, J.I. and Simpson, N.E. (1989) "A randomized trial of intensive insulin therapy in newly diagnosed insulin dependent diabetes mellitus". N. Eigl. J. Mud. 320, 350-354.
  • Shah, S.C. and Malone, J.I. (1991) "High dose insulin Therapy (HDIT) resulted in long term survival of betacell and disappearance of islet cell antibodies (ICA) in IDDM". Diabetes 40(Suppl. 1), 152A.
  • Bjork, E., Kampe, O., Andersson, A. and Karlsson, F.A. (1992) "Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion", Diabetologia 32, 490-493.
  • Kagimoto, S., Yamada, Y. Kubota, A., Ishida, H. and Seino, Y. (1996) "Apoptotic cell death of beta cells triggered by glibenclamide", Diabetologia 39(Suppl. 1), 404A.
  • Cabrera-Rode, E., Díaz-Horta, O., Rendón, A., Molina, G., Suárex, L.R., Perich, P. et al. (1998) "Prevalence and characteristics of latent autoimmune diabetes in a Cuban type 2 diabetes cohort", Diabetologia 41(Suppl. 1), Al70.
  • Trinder, P. (1969) "Determination of glucose oxidase with one alternative oxygen acceptor". Ann. Clin. Biochem. 6, 24-27.
  • Pilcher, C. and Elliott, R.B. (1984) "Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics", Lancer 1, 1352.
  • Mauricio, D., Corcoy, R., Codina, M., Morales, J., Balsells, M. and de Leiva, A. (1995) "Islet cell antibodies and beta-cell function in gestacional diabetes women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects". Diabet, Mud. 12, 1009-1014.
  • Grubin, C.E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagobian, W.A., Li, L., et al. (1994) "A novel radioligand binding assay to determine diagnostic accuracy of iso-form specific glutamic acid decarboxylase in a childhood population", Diubetolonia 37, 344-350.
  • Trischitta, V., Italia, S., Raimondo, M., Guardabasso, V., Licciardello, C., Runello, F., et al. (1998) "Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?", J Endocrinol. Investig. 21(11), 744-747.
  • Atkinson, M.A., MacLaren, N.K. and Luchetta, R. (1990) "Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy", Diabetes 39, 933-937.
  • Arthur, A.L. and Worcester, M. A. (1986) "Insulin injections prevent diabetes (DB) in Biobreeding/Worcester (BB/Wor) rats", Diabetes 35, 74A, (Abstract).
  • Sai, P., Damge, Ch., Riverau, A.S., Hoeltzei, A. and Gouin, E. (1996) "Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanocrylate nanocapsules reduces the incidence of diabetes in non obese diabetic mice", J. Autoimmun. 9, 713-721.
  • Seissler, J., de Sonnaville, J.J.J., Morgenthaler, N.G., Steinbrenner, H., Glawe, D., Khoo-Morgenthaler, U.Y. er al. (1998) "Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease", Diabetologia 41, 891-897.
  • Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., et al. (1999) "Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies", Diabetes. 150-157.
  • Cabrera-Rode, E., Molina, G., Díaz-Horta, O., Rendon, A., Perich, P., Snárez, L., et al. (1999) "Characteristics of islet cell antibodies in Latent Autoimmune Diabetes of Adult (LADA), Newly Diagnosed Type 1 Diabetes. First degree of relatives of type 1 diabetes and Gestational Diabetes", Rev. Cubana Endocrlnol. 10, 85-97.
  • Kobayashi, T., Nakanishi, K., Murase, T. and Kosaka, K. (1996) "Small doses of subcutaneous insulin as strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM", Diabetes 45, 622-626.
  • Naik, R.G. and Palmer, J.P. (1999) "Preservation of ß-cell function in type 1 diabetes". Diabetes Rev. 7, 154-182.
  • Pozzilli, P. and Di Mario, U. (2001) "Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention". Diabetes Care 24, 1460-1467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.